---
title: "Thrombin-cleaved osteopontin links AKI to hippocampal CCL2-driven neuroinflammation and acute deli"
id: "biorxiv-20-thrombin-cleavage-of-circulating-osteopontin-in-the-lung-drives-hippocampal"
canonical_url: "https://medichelpline.com/clinical-feed/biorxiv-20-thrombin-cleavage-of-circulating-osteopontin-in-the-lung-drives-hippocampal"
content_type: "clinical_feed_article"
specialty: "Nephrology"
source_name: "bioRxiv (Biomedical Preprints)"
source_url: "https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1?rss=1"
published_at: "2026-11-18T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Thrombin-cleaved osteopontin links AKI to hippocampal CCL2-driven neuroinflammation and acute deli
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/biorxiv-20-thrombin-cleavage-of-circulating-osteopontin-in-the-lung-drives-hippocampal
- **Specialty:** [Nephrology](https://medichelpline.com/clinical-feed/nephrology.md)
- **Primary Source:** bioRxiv (Biomedical Preprints)
- **Source URL:** [Original Journal Publication](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1?rss=1)
- **Published At:** 2026-11-18T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study used a mouse model of **acute kidney injury (AKI)** to probe mechanisms of rapid brain dysfunction after renal injury. - Investigators observed hippocampal monocytic neuroinflammation that correlated with acute behavioral deficits resembling **delirium** in uremic mice. - Data indicated the injured kidney released circulating **osteopontin (OPN/Spp1)**; the protein was cleaved by **thrombin** in the lung into two fragments termed OPN-N and OPN-C-terminal. - Both OPN fragments were required, in combination, to induce endothelial upregulation of the monocyte chemoattractant **CCL2** in the hippocampus, which preceded monocyte recruitment. - AKI mice genetically lacking OPN or unable to undergo thrombin-mediated OPN activation developed kidney injury and serum uremic toxin elevations comparable to wild-type controls but were protected from hippocampal **CCL2** upregulation, monocyte infiltration, and delirium-like behaviors. - Systemic administration of neutralizing antibodies against OPN or **CCL2** prevented hippocampal neuroinflammation and behavioral deficits in the AKI model. - The study team reported these results as challenging the dominant hypothesis that circulating uremic toxins are the primary drivers of AKI-associated acute brain dysfunction. - Authors proposed **thrombin** cleavage of OPN as a mechanistic switch and a potential therapeutic target; the source did not report dosing, timing, or specific antibody regimens in this summary abstract.
## Clinical Analysis & Structured Key Points
[](https://www.biorxiv.org/cdn-cgi/content?id=v.V5vJh_iyxgURaRL4yceqPunuGl8sc08CLiIahb7dg-1795038752.3336358-1.2.1.1-jESnQeIJfOTS8vVuKM_JwreamuL94doVxATJdgtjoIP_i2ERqe1VLd7Gg_oSPwnt) [Skip to main content](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1?rss=1#main-content) [![bioRxiv](https://www.biorxiv.org/sites/default/files/biorxiv_article_logo.jpg)](https://www.biorxiv.org/) * [Home](https://www.biorxiv.org/) * [Submit](https://www.biorxiv.org/submit-a-manuscript) * [FAQ](https://www.biorxiv.org/about/FAQ) * [Blog](https://connect.biorxiv.org/news/) * [ALERTS / RSS](https://www.biorxiv.org/content/alertsrss) * [Resources](https://connect.biorxiv.org/resources/) * [About](https://www.biorxiv.org/content/about-biorxiv) * [Channels](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1?rss=1) * [4D Nucleome](https://connect.biorxiv.org/relate/content/66) * [Academia Sinica](https://connect.biorxiv.org/group/content/38) * [Advances in Genome Biology and Technology (AGBT) General Meeting 2016 #AGBT16](https://connect.biorxiv.org/relate/content/10) * [Albert Einstein College of Medicine](https://connect.biorxiv.org/group/content/4) * [Aligning Science Across Parkinson's (ASAP)](https://connect.biorxiv.org/relate/content/195) * [Allen Institute for Cell Science](https://connect.biorxiv.org/relate/content/71) * [Arc Institute](https://connect.biorxiv.org/relate/content/224) * [Babraham Institute](https://connect.biorxiv.org/relate/content/197) * [BICCN/BICAN](https://connect.biorxiv.org/relate/content/208) * [BioImaging North America](https://connect.biorxiv.org/relate/content/194) * [Biology of Genomes 2016 #BOG16](https://connect.biorxiv.org/relate/content/19) * [Breakthrough Discoveries for Thriving with Bipolar Disorder](https://connect.biorxiv.org/relate/content/236) * [Brown University](https://connect.biorxiv.org/group/content/9) * [California Institute of Technology](https://connect.biorxiv.org/group/content/32) * [Carnegie Mellon University](https://connect.biorxiv.org/group/content/19) * [Case Western Reserve University](https://connect.biorxiv.org/group/content/36) * [Central Oxford Structural Microscopy and Imaging](https://connect.biorxiv.org/relate/content/143) * [Centre for Microbiology and Environmental Systems Science](https://connect.biorxiv.org/relate/content/190) * [Chan Zuckerberg Biohub](https://connect.biorxiv.org/relate/content/121) * [Columbia University](https://connect.biorxiv.org/group/content/27) * [Donders Institute for Brain, Cognition and Behaviour](https://connect.biorxiv.org/relate/content/184) * [DREAM](https://connect.biorxiv.org/relate/content/153) * [Drug Development and Clinical Therapeutics](https://connect.biorxiv.org/relate/content/52) * [ENCODE](https://connect.biorxiv.org/relate/content/177) * [Ernst Strüngmann Institute (ESI) for Neuroscience](https://connect.biorxiv.org/relate/content/211) * [European Molecular Biology Laboratory (EMBL)](https://connect.biorxiv.org/relate/content/159) * [Francis Crick Institute](https://connect.biorxiv.org/relate/content/88) * [Fred Hutchinson Cancer Center](https://connect.biorxiv.org/group/content/28) * [Georgia Institute of Technology](https://connect.biorxiv.org/group/content/20) * [Harvard Program in Therapeutic Sciences](https://connect.biorxiv.org/relate/content/151) * [The Howard Hughes Medical Institute (HHMI)](https://connect.biorxiv.org/relate/content/227) * [Human Cell Atlas](https://connect.biorxiv.org/relate/content/163) * [Human Pangenome Reference Consortium (HPRC)](https://connect.biorxiv.org/relate/content/215) * [IMO Workshop](https://connect.biorxiv.org/relate/content/8) * [Impact of Genomic Variation on Function (IGVF)](https://connect.biorxiv.org/relate/content/214) * [Institut Pasteur](https://connect.biorxiv.org/relate/content/235/channel) * [Institute of Science and Technology Austria](https://connect.biorxiv.org/group/content/12) * [International Human Epigenome Consortium (IHEC)](https://connect.biorxiv.org/relate/content/219) * [International Mouse Phenotyping Consortium (IMPC)](https://connect.biorxiv.org/relate/content/185) * [Iowa State University](https://connect.biorxiv.org/group/content/6) * [Johns Hopkins University](https://connect.biorxiv.org/group/content/47) * [Mathematical Oncology](https://connect.biorxiv.org/relate/content/1) * [Micron Oxford](https://connect.biorxiv.org/relate/content/116) * [Michigan State University](https://connect.biorxiv.org/group/content/7) * [Morgridge Institute](https://connect.biorxiv.org/group/content/57) * [National Taiwan University](https://connect.biorxiv.org/group/content/39) * [NCI Cancer Systems Biology Consortium](https://connect.biorxiv.org/relate/content/210) * [NF Open Science Initiative](https://connect.biorxiv.org/relate/content/213) * [NCI Human Tumor Atlas Network](https://connect.biorxiv.org/relate/content/171) * [Neuromatch Conference](https://connect.biorxiv.org/relate/content/209) * [NeurotechEU](https://connect.biorxiv.org/relate/content/189) * [North Carolina State University](https://connect.biorxiv.org/group/content/37) * [Northeastern University](https://connect.biorxiv.org/group/content/54) * [Oregon Health & Sciences University](https://connect.biorxiv.org/group/content/22) * [RNA Therapeutics Institute at UMass Chan Med School](https://connect.biorxiv.org/relate/content/243) * [Rosetta Commons](https://connect.biorxiv.org/relate/content/191) * [Rutgers University](https://connect.biorxiv.org/group/content/31) * [SeroNet](https://connect.biorxiv.org/relate/content/192) * [Simons Foundation Autism Research Initiative (SFARI)](https://connect.biorxiv.org/relate/content/74) * [Society for Molecular Biology and Evolution #SMBE2016](https://connect.biorxiv.org/relate/content/29) * [Somatic Cell Genome Editing Program](https://connect.biorxiv.org/relate/content/167) * [Somatic Mosaicism across the Human Tissues Network](https://connect.biorxiv.org/relate/content/222) * [SPARC](https://connect.biorxiv.org/relate/content/187) * [Stowers Institute for Medical Research](https://connect.biorxiv.org/group/content/3) * [Stockholm University](https://connect.biorxiv.org/group/content/14) * [Tel Aviv University](https://connect.biorxiv.org/group/content/8) * [The Michael J. Fox Foundation](https://connect.biorxiv.org/relate/content/207) * [The Rockefeller University](https://connect.biorxiv.org/group/content/2) * [The Sainsbury Laboratory](https://connect.biorxiv.org/relate/content/98) * [The Whitehead Institute](https://connect.biorxiv.org/relate/content/212) * [University of Connecticut Health Center](https://connect.biorxiv.org/group/content/16) * [University of California, Berkeley](https://connect.biorxiv.org/group/content/13) * [University of California, San Diego](https://connect.biorxiv.org/group/content/41) * [University of California, San Francisco](https://connect.biorxiv.org/group/content/10) * [University of Chicago](https://connect.biorxiv.org/group/content/42) * [University of Geneva](https://connect.biorxiv.org/group/content/26) * [University of Guelph](https://connect.biorxiv.org/group/content/23) * [University of Hong Kong](https://connect.biorxiv.org/group/content/29) * [University of Illinois Chicago](https://connect.biorxiv.org/group/content/43) * [University of Iowa](https://connect.biorxiv.org/group/content/24) * [University of Kansas](https://connect.biorxiv.org/group/content/33) * [University of Massachusetts Chan Medical School](https://connect.biorxiv.org/group/content/44) * [University of New South Wales](https://connect.biorxiv.org/group/content/25) * [University of Ottawa](https://connect.biorxiv.org/group/content/35) * [University of Sydney](https://connect.biorxiv.org/group/content/50) * [Vanderbilt University](https://connect.biorxiv.org/group/content/30) * [Vienna BioCenter](https://connect.biorxiv.org/relate/content/186) * [Washington University in St. Louis](https://connect.biorxiv.org/group/content/11) * [Weizmann Institute of Science](https://connect.biorxiv.org/group/content/15) * [Yale University](https://connect.biorxiv.org/group/content/53) Search for this keyword [Advanced Search](https://www.biorxiv.org/search) New Results Follow this preprint # Thrombin cleavage of circulating osteopontin in the lung drives hippocampal neuroinflammation and acute delirium-like neurologic dysfunction after acute kidney injury Poornima Dilhani Ekanayake Weerasinghe Mudiyanselage, Rupal Ojha, Liang Ning, Marta Celorrio Navarro, Leah Tolby, Anusha Suresh, John Morser, Lawrence Leung, Machiko Honda, Shigeyuki Kon, Stuart H. Friess, Andreas Herrlich doi: https://doi.org/10.64898/2026.11.17.767415 This article is a preprint and has not been certified by peer review [[what does this mean?](https://www.biorxiv.org/about/FAQ#unrefereed)]. Poornima Dilhani Ekanayake Weerasinghe Mudiyanselage 1 Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA and VA Saint Louis Health Care System, John Cochran Division, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Poornima%2BDilhani%2BEkanayake%2BWeerasinghe%2BMudiyanselage%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Weerasinghe%20Mudiyanselage%20PD&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3APoornima%2BDilhani%2BEkanayake%2BWeerasinghe%2BMudiyanselage%2B) Rupal Ojha 1 Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA and VA Saint Louis Health Care System, John Cochran Division, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Rupal%2BOjha%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Ojha%20R&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ARupal%2BOjha%2B) Liang Ning 1 Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA and VA Saint Louis Health Care System, John Cochran Division, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Liang%2BNing%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Ning%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALiang%2BNing%2B) Marta Celorrio Navarro 2 Division of Critical Care Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Marta%2BCelorrio%2BNavarro%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Celorrio%20Navarro%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMarta%2BCelorrio%2BNavarro%2B) Leah Tolby 3 Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Leah%2BTolby%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Tolby%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALeah%2BTolby%2B) Anusha Suresh 3 Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Anusha%2BSuresh%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Suresh%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAnusha%2BSuresh%2B) John Morser 4 3. Division of Critical Care Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA and 4. Division of Hematology, Stanford University School of Medicine, Stanford, California, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=John%2BMorser%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Morser%20J&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AJohn%2BMorser%2B) Lawrence Leung 5 Division of Critical Care Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA and Division of Hematology, Stanford University School of Medicine, Stanford, California, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Lawrence%2BLeung%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Leung%20L&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3ALawrence%2BLeung%2B) Machiko Honda 6 Department of Molecular Immunology, Faculty of Pharmaceutical Sciences, Fukuyama University, 985-1 Azasanzo, Higashimura-cho, Fukuyama, Hiroshima 729-0292, Japan * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Machiko%2BHonda%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Honda%20M&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AMachiko%2BHonda%2B) Shigeyuki Kon 6 Department of Molecular Immunology, Faculty of Pharmaceutical Sciences, Fukuyama University, 985-1 Azasanzo, Higashimura-cho, Fukuyama, Hiroshima 729-0292, Japan * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Shigeyuki%2BKon%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Kon%20S&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AShigeyuki%2BKon%2B) Stuart H. Friess 2 Division of Critical Care Medicine, Department of Pediatrics, Washington University School of Medicine, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Stuart%2BH.%2BFriess%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Friess%20SH&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AStuart%2BH.%2BFriess%2B) Andreas Herrlich 1 Division of Nephrology, Department of Medicine, Washington University School of Medicine, St. Louis, MO, USA and VA Saint Louis Health Care System, John Cochran Division, St. Louis, MO, USA; * [Find this author on Google Scholar](https://www.biorxiv.org/lookup/google-scholar?link_type=googlescholar&gs_type=author&author%5B0%5D=Andreas%2BHerrlich%2B "Open in new tab") * [Find this author on PubMed](https://www.biorxiv.org/lookup/external-ref?access_num=Herrlich%20A&link_type=AUTHORSEARCH "Open in new tab") * [Search for this author on this site](https://www.biorxiv.org/search/author1%3AAndreas%2BHerrlich%2B) * For correspondence: aherrlich@wustl.edu * [Abstract](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_art/node:5975102/1) * [Info/History](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1.article-info)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_info/node:5975102/1) * [Metrics](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1.article-metrics)[](https://www.biorxiv.org/panels_ajax_tab/article_tab_metrics/node:5975102/1) * [ Preview PDF](https://www.biorxiv.org/content/10.64898/2026.11.17.767415v1.full.pdf+html)[](https://www.biorxiv.org/panels_ajax_tab/biorxiv_tab_pdf/node:5975102/1) ![Loading](https://www.biorxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif) ## Abstract Acute kidney injury (AKI) is a common clinical problem with high morbidity and mortality due to frequently occurring secondary organ complications, including acute neurologic dysfunction, such as delirium. Specific mechanisms responsible for this kidney-brain crosstalk are unknown but hypothesized to include uremic toxins and neuroinflammation secondary to systemic inflammation. Here we show that uremic mice with AKI show hippocampal monocytic neuroinflammation associated with acute delirium-like neurologic dysfunction only in the presence of circulating osteopontin fragments. Mechanistically, circulating osteopontin (OPN/Spp1) released by the injured kidney was cleaved by thrombin in the lung into OPN-N and OPN-C-terminal fragments. Both OPN fragments were required to drive upregulation of the monocyte chemoattractant chemokine-ligand-2 (CCL2) in hippocampal endothelial cells. AKI mice lacking OPN or unable to activate OPN by thrombin cleavage showed kidney injury and serum uremic toxin elevations like wt controls but were protected from hippocampal CCL2 upregulation, monocyte recruitment, and delirium-like symptoms. Systemic application of an OPN or CCL2 neutralizing antibody was protective. Our results suggest that a specific kidney-released circulating factor, osteopontin, drives acute neurologic dysfunction after AKI and challenge the widely held hypothesis that uremic toxins play a dominant role. They also identify thrombin cleavage of OPN as a potential therapeutic target and critical switch for the remote functions of circulating OPN. ### Competing Interest Statement The authors have declared no competing interest. ## Funder Information Declared International Heart and Lung Institute United States Department of Veterans Affairs, https://ror.org/05rsv9s98, I01RD001486 American Society of Nephrology, https://ror.org/014pcm848, Benn J. Lipps Research Fellowship award Copyright The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. bioRxiv and medRxiv thank the following for their generous financial support: > The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, The University of Edinburgh, University o
## Related Clinical Research

- [Single-nucleus long-read RNA sequencing finds isoform shifts in mouse acute kidney injury](https://medichelpline.com/clinical-feed/biorxiv-21-single-nucleus-long-read-rna-sequencing-reveals-isoform-usage-shifts-in-mouse.md)
- [SMEF reduces early ischemic kidney injury and suppresses inflammatory program in pigs](https://medichelpline.com/clinical-feed/biorxiv-1-a-synchronization-modulation-electric-field-reduces-early-ischemic-kidney.md)
- [Sedative Prescriptions After Discharge Linked To Adverse Events In Older Adults](https://medichelpline.com/clinical-feed/cmaj-0-association-between-sedative-prescriptions-after-hospital-discharge-and-falls.md)
- [Emergency Peritoneal Dialysis in Neonates: Nasogastric Tube Access vs Tenckhoff Catheters](https://medichelpline.com/clinical-feed/medrxiv-3-emergency-manual-peritoneal-dialysis-using-adapted-nasogastric-tubes-versus.md)
- [Renal Consequences of Inhaled Nitric Oxide in Critically Ill Patients](https://medichelpline.com/clinical-feed/pubmed-43061996.md) (DOI: 10.4103/mgr.MEDGASRES-D-26-00116)

## Navigation
- [← Back to Nephrology Feed](https://medichelpline.com/clinical-feed/nephrology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.